Updated:
Meidlinger Partners
Meidlinger Partners invests in water technology companies with scalable solutions to address global water issues. The firm focuses on companies that develop...
Meidlinger Partners
Meidlinger Partners invests in water technology companies with scalable solutions to address global water issues. The firm focuses on companies that develop energy-efficient water and wastewater treatment technologies. Meidlinger Partners invests in companies serving government and industrial clients, including utilities and manufacturers of metals, wood, paper, chemicals, and power.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
—
Country
—
City
—
Corporate office
—
Principals
Lee Meidlinger
Managing Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Meidlinger Partners?
Lee Meidlinger serves as Managing Partner and directs all investment decisions. His background spans founding and operating health care staffing and services companies, which directly shapes the firm's preference for commercial-stage assets where operational intervention can accelerate growth.
What investment stages does Meidlinger Partners typically target?
The firm focuses on later-stage, revenue-generating health care companies. It explicitly avoids preclinical and early discovery-stage biotech, preferring devices, diagnostics, and tech-enabled services that have secured regulatory clearance and begun commercial sales.
Does Meidlinger Partners participate in fund commitments or only direct deals?
Meidlinger Partners deploys capital exclusively through direct equity investments. The firm does not operate as a fund-of-funds or allocate to external managers, reflecting its conviction that operator-led direct investing in concentrated positions produces better alignment.
How does Meidlinger Partners source proprietary deal flow?
The firm sources opportunities through Lee Meidlinger's personal network of health care executives, clinicians, and intermediaries built over a multi-decade operating career. Its reputation as a knowledgeable, patient capital provider in health care services and medtech generates inbound proprietary opportunities, particularly in the Southeastern US.
Which sectors does Meidlinger Partners explicitly avoid?
The firm does not invest in preclinical biotechnology, pharmaceuticals, or discovery-stage therapeutics. It also stays away from health care segments unrelated to its operator expertise, such as hospital real estate or pure-play health insurance, maintaining a tight focus on devices, diagnostics, and services.
Where does the underlying wealth come from?
Lee Meidlinger's wealth originated from founding and scaling health care staffing and services businesses. The commercial success of these operating companies provided the capital base that Meidlinger Partners now deploys into direct health care investments.
Is Meidlinger Partners structured as a single family office or does it operate more like a venture firm?
Legally and structurally, Meidlinger Partners is a single-family office investing Lee Meidlinger's personal capital. Its investment posture, however, resembles a specialized growth-equity firm — taking board seats, shaping commercial strategy, and holding concentrated positions — but with permanent capital and no external limited partners.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: